Proteomics in Thrombosis and Hemostasis.

Natasha Letunica, Suelyn Van Den Helm, Conor McCafferty, Ella Swaney, Tengyi Cai, Chantal Attard, Vasiliki Karlaftis, Paul Monagle, Vera Ignjatovic

Thrombosis and haemostasis 2022 Jul

filter terms:

Proteomics, the simultaneous study of all proteins in a given cell, tissue or organism, is an innovative approach used to identify novel markers for diagnosis, prognosis and the pathophysiological mechanisms associated with diseases. Proteomic methodologies have been used in a variety of contexts such as investigating changes in protein abundance that may occur with disease presence, the response to therapeutic treatments as well as the impacts of age on the plasma proteome.Over the last decade, significant technological advancements in proteomic techniques have resulted in an increase in the use of proteomics in thrombosis and hemostasis research, particularly in order to identify relevant and novel clinical markers associated with bleeding and thrombosis. This mini-review explores the use of proteomics in the setting of thrombosis and hemostasis from 2010-2020, across five main domains (platelets, blood clot composition, stroke, venous thromboembolism, and therapeutics), as well as provides insights into key considerations for conducting proteomic studies. Thieme. All rights reserved.

Citation

Natasha Letunica, Suelyn Van Den Helm, Conor McCafferty, Ella Swaney, Tengyi Cai, Chantal Attard, Vasiliki Karlaftis, Paul Monagle, Vera Ignjatovic. Proteomics in Thrombosis and Hemostasis. Thrombosis and haemostasis. 2022 Jul;122(7):1076-1084